Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer:the OPUS study .Randomized,phase Ⅲ trial of panitumumab with infusional fluorouracil,leucovorin,and oxaliplatin(FOLFOX4)versus FOLFO ......